The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection

MLA

Judith J. Lok, et al. “The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection.” Clinical Infectious Diseases, vol. 65, July 2017, pp. 2042–49. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f06c90d14c7e11f7be14b2c5fb0ae286&authtype=sso&custid=ns315887.

APA

Judith J. Lok, Thomas B. Campbell, Jose R Castillo-Mancilla, Kristine M. Erlandson, C. William Wester, Robert C. Kalayjian, Susan L. Koletar, Edgar T. Overton, Douglas Kitch, Constance A. Benson, & Kevin Robertson. (2017). The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection. Clinical Infectious Diseases, 65, 2042–2049.

Chicago

Judith J. Lok, Thomas B. Campbell, Jose R Castillo-Mancilla, Kristine M. Erlandson, C. William Wester, Robert C. Kalayjian, Susan L. Koletar, et al. 2017. “The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection.” Clinical Infectious Diseases 65 (July): 2042–49. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f06c90d14c7e11f7be14b2c5fb0ae286&authtype=sso&custid=ns315887.